The effect of disease-modifying antirheumatic drugs on vaccine immunogenicity in adults

Alvin Lee Day; Kevin L. Winthrop; Jeffrey R. Curtis

doi:10.3949/ccjm.87a.20056

The effect of disease-modifying antirheumatic drugs on vaccine immunogenicity in adults

Alvin Lee Day, Kevin L. Winthrop, Jeffrey R. Curtis

Ophthalmology

Research output: Contribution to journal › Article › peer-review

17 Scopus citations

Abstract

Patients with immunocompromising conditions are at higher risk of vaccine-preventable infections. Further, those receiving immunosuppressive disease-modifying antirheumatic drugs (DMARDs) can have variable responses to vaccines depending on which vaccine and which DMARD they are receiving.

Original language	English (US)
Pages (from-to)	695-703
Number of pages	9
Journal	Cleveland Clinic journal of medicine
Volume	87
Issue number	11
DOIs	https://doi.org/10.3949/ccjm.87a.20056
State	Published - Nov 2020

Keywords

Influenza vaccine should be given yearly to all patients on DMARDs
with modification to either the timing of DMARD or vaccine administration for patients receiving methotrexate or rituximab

ASJC Scopus subject areas

Medicine(all)

Access to Document

10.3949/ccjm.87a.20056

Cite this

@article{647e239e4ddb4e45b0edf6cbbe3d3e7f,

title = "The effect of disease-modifying antirheumatic drugs on vaccine immunogenicity in adults",

abstract = "Patients with immunocompromising conditions are at higher risk of vaccine-preventable infections. Further, those receiving immunosuppressive disease-modifying antirheumatic drugs (DMARDs) can have variable responses to vaccines depending on which vaccine and which DMARD they are receiving.",

keywords = "Influenza vaccine should be given yearly to all patients on DMARDs, with modification to either the timing of DMARD or vaccine administration for patients receiving methotrexate or rituximab",

author = "Day, {Alvin Lee} and Winthrop, {Kevin L.} and Curtis, {Jeffrey R.}",

year = "2020",

month = nov,

doi = "10.3949/ccjm.87a.20056",

language = "English (US)",

volume = "87",

pages = "695--703",

journal = "Cleveland Clinic Journal of Medicine",

issn = "0891-1150",

publisher = "Cleveland Clinic Educational Foundation",

number = "11",

}

TY - JOUR

T1 - The effect of disease-modifying antirheumatic drugs on vaccine immunogenicity in adults

AU - Day, Alvin Lee

AU - Winthrop, Kevin L.

AU - Curtis, Jeffrey R.

PY - 2020/11

Y1 - 2020/11

N2 - Patients with immunocompromising conditions are at higher risk of vaccine-preventable infections. Further, those receiving immunosuppressive disease-modifying antirheumatic drugs (DMARDs) can have variable responses to vaccines depending on which vaccine and which DMARD they are receiving.

AB - Patients with immunocompromising conditions are at higher risk of vaccine-preventable infections. Further, those receiving immunosuppressive disease-modifying antirheumatic drugs (DMARDs) can have variable responses to vaccines depending on which vaccine and which DMARD they are receiving.

KW - Influenza vaccine should be given yearly to all patients on DMARDs

KW - with modification to either the timing of DMARD or vaccine administration for patients receiving methotrexate or rituximab

UR - http://www.scopus.com/inward/record.url?scp=85095389670&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85095389670&partnerID=8YFLogxK

U2 - 10.3949/ccjm.87a.20056

DO - 10.3949/ccjm.87a.20056

M3 - Article

C2 - 33139263

AN - SCOPUS:85095389670

SN - 0891-1150

VL - 87

SP - 695

EP - 703

JO - Cleveland Clinic Journal of Medicine

JF - Cleveland Clinic Journal of Medicine

IS - 11

ER -

The effect of disease-modifying antirheumatic drugs on vaccine immunogenicity in adults

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this